We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA REVISES PREMARKET VALIDATION REQUIREMENTS
FDA REVISES PREMARKET VALIDATION REQUIREMENTS
March 19, 2004
A revised guide issued last week by the FDA may exempt drugmakers using advanced technologies to ensure batch quality from having to produce multiple validation batches before the initial distribution of a new drug.